These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 6506894)

  • 1. [Histomorphologic studies of prostate biopsies, prostatectomy preparations and lymph node metastases in prostatic cancer].
    Schubert J; Battke H; Hoffmann L; Raatzsch H
    Z Urol Nephrol; 1984 Sep; 77(9):521-8. PubMed ID: 6506894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of microinvasion of the capsule and/or micrometastasis of regional lymph nodes on disease free survival after radical prostatectomy.
    Hering F; Schmid HP; Graber P
    Ann Urol (Paris); 1994; 28(4):196-201. PubMed ID: 7979209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percentage of positive biopsies predicts lymph node involvement in men with low-risk prostate cancer undergoing radical prostatectomy and extended pelvic lymphadenectomy.
    Heidenreich A; Pfister D; Thüer D; Brehmer B
    BJU Int; 2011 Jan; 107(2):220-5. PubMed ID: 20590538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis.
    Heidenreich A; Varga Z; Von Knobloch R
    J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preoperative assessment of tumor aggressiveness in localized prostatic carcinoma].
    Hammerer P; Henke RP; Hübner D; Huland H
    Urologe A; 1995 Sep; 34(5):413-8. PubMed ID: 7483160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lymphogenic metastases in prostatic cancer--operative and histopathologic investigations ].
    Schubert J; Heidl G
    Arch Geschwulstforsch; 1982 May; 52(3):213-21. PubMed ID: 7125858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results.
    Maffezzini M
    J Urol; 2005 Sep; 174(3):1151-2; author reply 1152. PubMed ID: 16094087
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymph node assessment and lymphadenectomy in prostate cancer.
    Ordon M; Nam RK
    J Surg Oncol; 2009 Mar; 99(4):215-24. PubMed ID: 19170044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer.
    Cagiannos I; Karakiewicz P; Eastham JA; Ohori M; Rabbani F; Gerigk C; Reuter V; Graefen M; Hammerer PG; Erbersdobler A; Huland H; Kupelian P; Klein E; Quinn DI; Henshall SM; Grygiel JJ; Sutherland RL; Stricker PD; Morash CG; Scardino PT; Kattan MW
    J Urol; 2003 Nov; 170(5):1798-803. PubMed ID: 14532779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The significance of pelvic lymph-node status in prostatic cancer].
    Schubert J; Heidl G; Nitzsche H; Wehnert J; Moravek P
    Z Urol Nephrol; 1983 Dec; 76(12):763-70. PubMed ID: 6199912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of pelvic lymphadenectomy in the therapy of prostate and bladder cancer].
    Heidenreich A; Ohlmann CH
    Aktuelle Urol; 2005 Jun; 36(3):219-29. PubMed ID: 16001337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is a limited lymphadenectomy targeting obturator nodes alone an adequate procedure for Japanese men undergoing radical prostatectomy?
    Miyake H; Sakai I; Harada K; Hara I; Eto H
    Int J Urol; 2005 Aug; 12(8):739-44. PubMed ID: 16174048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radical prostatectomy for localized prostate cancer].
    Arakawa S; Hara I; Miyake H; Taguchi I; Yamada Y; Gotoh A; Ueno K; Matsui T; Fujisawa M; Eto H; Gohji K; Okada H; Kamidono S
    Hinyokika Kiyo; 1996 Oct; 42(10):811-5. PubMed ID: 8951480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
    Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
    Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of prostate micrometastases in pelvic lymph nodes: an archival tissue study.
    Edelstein RA; Zietman AL; de las Morenas A; Krane RJ; Babayan RK; Dallow KC; Traish A; Moreland RB
    Urology; 1996 Mar; 47(3):370-5. PubMed ID: 8633404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical techniques in prostate cancer].
    Schmeller NT
    Fortschr Med; 1991 Sep; 109(28):559-62. PubMed ID: 1836775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic lymphadenectomy as staging before definitive treatment of prostatic carcinoma.
    Elfving P; Lundgren R
    Scand J Urol Nephrol Suppl; 1988; 110():155-61. PubMed ID: 3142034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
    Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
    Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Value of biopsies in staging of prostatic cancer before radical prostatectomy].
    Salomon L; Hoznek A; Lefrere-Belda MA; Bellot J; Chopin D; Abbou CC
    Prog Urol; 1998 Dec; 8(6):969-76. PubMed ID: 9894255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.